127 related articles for article (PubMed ID: 37423611)
1. Efficacy of stereotactic radiation therapy for the treatment of confirmed or presumed canine glioma.
Trageser E; Martin T; Burdekin B; Hart C; Leary D; LaRue S; Boss MK
Vet Comp Oncol; 2023 Dec; 21(4):578-586. PubMed ID: 37423611
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of frameless stereotactic radiotherapy for the treatment of presumptive canine intracranial gliomas: A retrospective analysis (2014-2017).
Moirano SJ; Dewey CW; Haney S; Yang J
Vet Comp Oncol; 2020 Dec; 18(4):528-537. PubMed ID: 32011065
[TBL] [Abstract][Full Text] [Related]
3. Definitive-intent uniform megavoltage fractioned radiotherapy protocol for presumed canine intracranial gliomas: retrospective analysis of survival and prognostic factors in 38 cases (2013-2019).
Debreuque M; De Fornel P; David I; Delisle F; Ducerveau MN; Devauchelle P; Thibaud JL
BMC Vet Res; 2020 Oct; 16(1):412. PubMed ID: 33129320
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes and target delineation utilizing CT and MRI in 13 dogs treated with a uniform stereotactic radiation therapy protocol (16 Gy single fraction) for pituitary masses: (2014-2017).
Gieger TL; Nolan MW
Vet Comp Oncol; 2021 Mar; 19(1):17-24. PubMed ID: 32548944
[TBL] [Abstract][Full Text] [Related]
5. Frameless stereotactic radiotherapy alone and combined with temozolomide for presumed canine gliomas.
Dolera M; Malfassi L; Bianchi C; Carrara N; Finesso S; Marcarini S; Mazza G; Pavesi S; Sala M; Urso G
Vet Comp Oncol; 2018 Mar; 16(1):90-101. PubMed ID: 28643878
[TBL] [Abstract][Full Text] [Related]
6. Outcome After Radiation Therapy in Canine Intracranial Meningiomas or Gliomas.
MagalhÃes TR; BenoÎt J; NÉČovÁ S; North S; Queiroga FL
In Vivo; 2021; 35(2):1117-1123. PubMed ID: 33622909
[TBL] [Abstract][Full Text] [Related]
7. Perfusion and Volume Response of Canine Brain Tumors to Stereotactic Radiosurgery and Radiotherapy.
Zwingenberger AL; Pollard RE; Taylor SL; Chen RX; Nunley J; Kent MS
J Vet Intern Med; 2016 May; 30(3):827-35. PubMed ID: 27149650
[TBL] [Abstract][Full Text] [Related]
8. Re-irradiation of canine non-lymphomatous nasal tumours using stereotactic radiation therapy (10 Gy x 3) for both courses: Assessment of outcome and toxicity in 11 dogs.
Gieger TL; Haney SM; Nolan MW
Vet Comp Oncol; 2022 Jun; 20(2):502-508. PubMed ID: 35023604
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiation therapy for canine multilobular osteochondrosarcoma: Eight cases.
Sweet KA; Nolan MW; Yoshikawa H; Gieger TL
Vet Comp Oncol; 2020 Mar; 18(1):76-83. PubMed ID: 30989784
[TBL] [Abstract][Full Text] [Related]
10. Linac-based stereotactic radiation therapy for canine non-lymphomatous nasal tumours: 29 cases (2013-2016).
Gieger TL; Nolan MW
Vet Comp Oncol; 2018 Mar; 16(1):E68-E75. PubMed ID: 28741887
[TBL] [Abstract][Full Text] [Related]
11. Single fraction stereotactic radiation therapy (stereotactic radiosurgery) is a feasible method for treating intracranial meningiomas in dogs.
Kelsey KL; Gieger TL; Nolan MW
Vet Radiol Ultrasound; 2018 Sep; 59(5):632-638. PubMed ID: 29873144
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study of sinonasal tumors in 182 dogs treated with stereotactic radiotherapy (3 × 10 Gy) (2010-2015).
Yoshikawa H; Lafferty MH; Griffin LR; LaRue SM
J Vet Intern Med; 2023; 37(6):2356-2367. PubMed ID: 37688322
[TBL] [Abstract][Full Text] [Related]
13. Primary irradiation of canine intracranial masses.
Spugnini EP; Thrall DE; Price GS; Sharp NJ; Munana K; Page RL
Vet Radiol Ultrasound; 2000; 41(4):377-80. PubMed ID: 10955504
[TBL] [Abstract][Full Text] [Related]
14. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):293-8. PubMed ID: 10030252
[TBL] [Abstract][Full Text] [Related]
15. Outcome of 9 dogs treated with stereotactic radiation therapy for primary or metastatic vertebral osteosarcoma.
Swift KE; LaRue SM
Vet Comp Oncol; 2018 Mar; 16(1):E152-E158. PubMed ID: 29181871
[TBL] [Abstract][Full Text] [Related]
16. Survival times in dogs with presumptive intracranial gliomas treated with oral lomustine: A comparative retrospective study (2008-2017).
Moirano SJ; Dewey CW; Wright KZ; Cohen PW
Vet Comp Oncol; 2018 Dec; 16(4):459-466. PubMed ID: 29797768
[TBL] [Abstract][Full Text] [Related]
17. Association of magnetic resonance imaging-based preoperative tumor volume with postsurgical survival time in dogs with primary intracranial glioma.
MacLellan JD; Arnold SA; Dave AC; Hunt MA; Pluhar GE
J Am Vet Med Assoc; 2018 Jan; 252(1):98-102. PubMed ID: 29244602
[TBL] [Abstract][Full Text] [Related]
18. CyberKnife stereotactic radiotherapy for treatment of primary intracranial tumors in dogs.
Carter GL; Ogilvie GK; Mohammadian LA; Bergman PJ; Lee RP; Proulx DR
J Vet Intern Med; 2021 May; 35(3):1480-1486. PubMed ID: 33755255
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival with stereotactic radiotherapy for imaging-diagnosed pituitary tumors in dogs.
Hansen KS; Zwingenberger AL; Théon AP; Kent MS
Vet Radiol Ultrasound; 2019 Mar; 60(2):219-232. PubMed ID: 30575174
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of dogs with thymoma treated with intensity modulated stereotactic body radiation therapy or non-modulated hypofractionated radiation therapy.
Trageser E; Martin T; Hoaglund E; Leary D; LaRue S; Boss MK
Vet Comp Oncol; 2022 Jun; 20(2):491-501. PubMed ID: 34936172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
